An innovative basic sector.
Beyond the pandemic, which meant an obvious boost to the sector, the pharmaceutical industry is one of the key contributors to the Spanish economy.
The arrival of digitization and new technologies is affecting the entire value chain of the sector, improving its efficiency, accelerating research and development times for new medications, or generating new distribution solutions and logistics.
The advent of telemedicine, wearable devices, Big Data, and Artificial Intelligence represent new tools that offer the pharmaceutical industry opportunities for diversification in its business models, bringing it closer to the end consumer.
Health as the basis of development.
A population in need of new value propositions offers new opportunities.
Innovation as tradition.
The assimilation of new technologies is seen as a natural investment.
Unstoppable growth.
The increase in investments and sector mergers as a key factor for growth.
New opportunities hand in hand with technology.
In addition to the improvements in research, processes, production, or distribution that new technologies are offering to the sector, technology provides the opportunity to launch new business lines closer to the end customer.
The hyperconnectivity offered by smart devices, data diagnosis by artificial intelligence, or the normalization of telemedicine in the population, offer new business opportunities that allow the industry not only to constantly improve its products, but also to create new services.
The speed of evolution of these technologies highlights the need to rethink the sector's paradigms and offer new value propositions.
